NHTC vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NHTC presents as a classic value trap, characterized by a stable Piotroski F-Score of 5/9 but severe operational decay. While the balance sheet is healthy with very low debt and strong liquidity, the company is experiencing negative revenue growth and negative profit margins. Most critically, the 13.99% dividend is completely unsustainable with a payout ratio of 2666.67%, suggesting a likely dividend cut. Technicals are purely bearish (0/100), and the stock is in a clear long-term downtrend.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
NHTC vs TSLA: Head-to-Head Comparison
This page compares Natural Health Trends Corp. (NHTC) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.